Higher Intake of Whole Grains May Lower Risk for Liver Cancer
Whole grains and possibly cereal fiber, bran appear linked to lower risk for hepatocellular carcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 4, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Journal, Source Type: news

Higher Intake of Whole Grains May Lower Risk for Liver Cancer
MONDAY, March 4, 2019 -- Higher intake of whole grains may be associated with a lower risk for hepatocellular carcinoma (HCC) among U.S. adults, according to a study published online Feb. 21 in JAMA Oncology. Wanshui Yang, Ph.D., from Anhui Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 4, 2019 Category: Pharmaceuticals Source Type: news

Cannabis can reverse the effects of alcohol-induced liver damage
(Natural News) A January 2018 study published in Liver International concluded that cannabis may reduce the incidence of liver disease in alcoholics. The study found that using cannabis correctly significantly lowered the odds of various liver diseases such as hepatitis, cirrhosis, and even hepatocellular carcinoma, a type of liver cancer. These findings were based on... (Source: NaturalNews.com)
Source: NaturalNews.com - March 1, 2019 Category: Consumer Health News Source Type: news

Eating More Whole Grains Tied to Lower Liver Cancer Risk Eating More Whole Grains Tied to Lower Liver Cancer Risk
Higher intake of whole grains was associated with reduced risk of hepatocellular carcinoma (HCC) in a large, long follow-up cohort study.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nonalcoholic fatty liver disease, commonly associated with diabetes, increases the risk of heart disease, and liver, colorectal, and breast cancers
(Natural News) In a new study that was published in the Journal of Hepatology, researchers were able to surmise that nonalcoholic fatty liver disease (NAFLD) is not only associated with hepatocellular carcinoma (HCC), but also to cancers that have nothing to do with the liver, such as colorectal and breast cancers. “NAFLD is a very... (Source: NaturalNews.com)
Source: NaturalNews.com - February 21, 2019 Category: Consumer Health News Source Type: news

Could whole grains, dietary fiber be associated with lower risk of liver cancer?
(JAMA Network) This   study used data for participants followed-up for 24 years as part of two well-known study groups to examine the association between whole grain and dietary fiber intake with the risk of hepatocellular carcinoma, a predominant form of liver cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2019 Category: Cancer & Oncology Source Type: news

Direct - Acting Antivirals Cut Mortality in Chronic Hepatitis C
Mortality, hepatocellular carcinoma risk reduced after adjustment for potential confounders (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 12, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Infections, Oncology, Pharmacy, Journal, Source Type: news

Direct-Acting Antivirals Cut Mortality in Chronic Hepatitis C
TUESDAY, Feb. 12, 2019 -- For adults with chronic hepatitis C virus (HCV) infection, direct-acting antivirals are associated with a reduced risk for mortality and hepatocellular carcinoma, according to a study published online Feb. 11 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 12, 2019 Category: Pharmaceuticals Source Type: news

Hep C Antivirals Tied to Lower Mortality and Cancer Risk
(MedPage Today) -- 52% drop in all-cause mortality, 34% drop in hepatocellular carcinoma cases (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - February 11, 2019 Category: Gastroenterology Source Type: news

Crunching the data: New liver cancer subtypes revealed immunologically
(Tokyo Medical and Dental University) Tokyo Medical and Dental University (TMDU) researchers used substantial datasets on liver cancer patients to develop a new classification of hepatocellular carcinoma (HCC) into three distinct subgroups with different genetic, immunological, and clinical features. The findings of HCC subtypes related to metabolic disease, immunosuppression, or mitogenic/stem-cell-like tumors should aid the development of more targeted treatment and promote the fight against this devastating disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 1, 2019 Category: Biology Source Type: news

Fibrosis Markers Tied to Mortality After Liver Cancer Surgery Fibrosis Markers Tied to Mortality After Liver Cancer Surgery
Noninvasive markers of fibrosis are associated with perioperative mortality and survival after liver resection for hepatocellular carcinoma, a retrospective study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 29, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

BTG touts use of radiopaque drug-eluting bead
BTG (LON:BTG) said this month that an Australian patient was treated with its radiopaque drug-eluting bead. The DC Bead Lumi product is the first commercial drug-eluting bead that can be loaded with doxorubicin or irinotecan to treat tumors in patients with hepatocellular carcinoma and liver metastases from colorectal cancer, according to BTG. Get the full story at our sister site, Drug Delivery Business News. The post BTG touts use of radiopaque drug-eluting bead appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 28, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured Oncology Pharmaceuticals Wall Street Beat BTG Source Type: news

Direct-Acting Antivirals Not Tied to Liver Cancer Recurrence
FRIDAY, Jan. 25, 2019 -- Direct-acting antiviral (DAA) therapy is not associated with increased overall or early hepatocellular carcinoma (HCC) recurrence among patients with a previous complete response to HCC treatment, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2019 Category: Pharmaceuticals Source Type: news

NHS England beats off drug company challenge
High Court dismisses AbbVie ’s case against NHS England’s hepatitis C programme Related items fromOnMedica England aims to be first in the world to eliminate hepatitis C Hepatocellular carcinoma risk, cirrhosis and hepatitis C New drive launched to trace hepatitis C patients Deaths from hepatitis C drop 11% in past year (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 23, 2019 Category: UK Health Source Type: news

Are Response Rates Predictive of Survival Outcome in HCC?
An analysis found that tumor response as assessed using modified RECIST criteria is an independent predictor of overall survival in hepatocellular carcinoma patients. (Source: CancerNetwork)
Source: CancerNetwork - January 20, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Liver Transplant Survival May Improve With Race Matching
WEDNESDAY, Jan. 16, 2019 -- For African-American patients with hepatocellular carcinoma (HCC) undergoing liver transplantation, donor-recipient race matching is associated with improved survival, according to a study published online Jan. 10 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 16, 2019 Category: Pharmaceuticals Source Type: news

Perfusion technique could boost number of viable donor livers
Slows rate of tissue deterioration and lengthens storage time, says NICE Related items fromOnMedica Primary sclerosing cholangitis New drive launched to trace hepatitis C patients Hepatocellular carcinoma risk, cirrhosis and hepatitis C Deaths from hepatitis C drop 11% in past year Alcohol consumption in late teens can predict risk of liver problems later (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 16, 2019 Category: UK Health Source Type: news

Cabozantinib Now Also FDA Approved for Liver Cancer Cabozantinib Now Also FDA Approved for Liver Cancer
A new indication allows cabozantinib to be used in patients with hepatocellular carcinoma who have previously been treated with sorafenib.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
ALAMEDA, Calif.--(BUSINESS WIRE)--Jan. 14, 2019-- Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 14, 2019 Category: Drugs & Pharmacology Source Type: news

Blacks With HCC May Live Longer If Liver Donor Is Black Blacks With HCC May Live Longer If Liver Donor Is Black
For black Americans with hepatocellular carcinoma (HCC) treated with a liver transplant, overall survival beyond 1 year was improved if the liver donor was also a black American.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Estimating the Impact of Early HCV Clearance on HCC Risk Estimating the Impact of Early HCV Clearance on HCC Risk
Does earlier HCV treatment initiation substantially reduce hepatocellular carcinoma risk?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Prior HCC and Risk of Treatment Failure With DAAs for HCV Prior HCC and Risk of Treatment Failure With DAAs for HCV
How does a prior history of hepatocellular carcinoma influence the therapeutic results of direct-acting antivirals in patients with chronic HCV infection?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Therapy for Hepatocellular Carcinoma: Beyond Sorafenib Therapy for Hepatocellular Carcinoma: Beyond Sorafenib
Immunotherapy and protein kinase inhibitors show promise for the treatment of advanced HCC.Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 26, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Medical scientists describe optimal immune therapeutic strategies for liver cancer
(The Korea Advanced Institute of Science and Technology (KAIST)) KAIST medical scientists have presented a novel pathways involving T immune cell exhaustion, providing evidence and rationale for designing optimal strategies for immune checkpoint blockades in cancer patients. They succeeded in distinguishing the hepatocellular carcinoma group from the exhausted tumor infiltrating immune cell composition of liver cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 26, 2018 Category: Cancer & Oncology Source Type: news

Curing HCV in Patients With HCC While Treating Cancer? Curing HCV in Patients With HCC While Treating Cancer?
Whether or not HCV patients with active hepatocellular carcinoma should be treated with DAAs remains controversial. This review examines the issues, presenting the current state of knowledge.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

‘ Alarming ’ : Projected Burden of Liver Cancer in the US ‘ Alarming ’ : Projected Burden of Liver Cancer in the US
The incidence of hepatocellular carcinoma in the US has been rapidly rising, but experts are cautiously optimistic that the trend can be reversed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

BTG Announces National Reimbursement for TheraSphere(R) in France
An estimated 500 patients per year in France could be eligible for treatment with TheraSphere® LONDON, December 21, 2018 -- (Healthcare Sales & Marketing Network) -- BTG plc (LSE: BTG), a global specialist healthcare company, today announced that t... Devices, Oncology, Reimbursement BTG, TheraSphere, Yttrium-90, Glass Microspheres, hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 21, 2018 Category: Pharmaceuticals Source Type: news

Neuromics FBS at 259 USD/500 ml.
Only 2 Weeks LeftWe wanted to get ourFBS in the hands of more cell culturing experts. Our low pricing has accelerated purchasing of this culture supplement.More importantly, we are pleased with the positive feedback. Here are some recentreviews.Linda S.on BirdEye  ★★★★★9 days agoMy experience with Neuromics was very positive. I asked for a sample of FBS and after to use the FBS I received. Peter T.on BirdEye ★★★★★month agoI purchased FBS from Neuromics. It was shipped to Canada without any problems. It arrived safely and still frozen. Cells grow well in the product. Customer ser...
Source: Neuromics - December 15, 2018 Category: Neuroscience Tags: FBS Fetal Bovine Serum Source Type: news

Risk Factors Identified for Late Recurrence of Liver Cancer
THURSDAY, Dec. 13, 2018 -- Late recurrence after hepatocellular carcinoma (HCC) resection is associated with sex, cirrhosis, and several aggressive tumor characteristics of the initial HCC, according to a study recently published in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2018 Category: Pharmaceuticals Source Type: news

Metformin and Risk of HCC in Patients With T2DM Metformin and Risk of HCC in Patients With T2DM
Is metformin use associated with a reduced risk of hepatocellular carcinoma in patients with type 2 diabetes mellitus?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 3, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

In Older Hep B Patients, Carcinoma Surveillance Is Advised In Older Hep B Patients, Carcinoma Surveillance Is Advised
Patients older than 50 years should still be screened for hepatocellular carcinoma after the 5 years of therapy for chronic hepatitis B, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Liver Disease Risk Factors in Patients Treated for Alcohol and Drug Dependence
Conclusion As this was only a pilot study, further data collection involving a larger, representative sample of clients should be undertaken to explore these results further. References Bennett, H. et al., 2015. Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections. PLoS ONE, 10(5), p.e0125846. Edeghere, O. et al., 2015. Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. Public Health, 129(5), pp.509–5...
Source: Alcohol Research UK - November 15, 2018 Category: Addiction Authors: admin Tags: Alcohol Insights Source Type: news

Metastasis in Patients With Hepatocellular Carcinoma Metastasis in Patients With Hepatocellular Carcinoma
This authors investigated the prevalence, associated factors, and prognostic impact of metastasis in hepatocellular carcinoma, proposing a modified BCLC system based on metastasis.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Osteopontin: A new emerging role in HCV-related hepatocellular carcinoma
(Kanazawa University) A research team based in Japan led by Kanazawa University has demonstrated the effect of osteopontin on hepatitis C virus replication and interferon signaling in cancer stem cells. Their research sheds light on a novel therapeutic target for treating hepatocellular carcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2018 Category: Cancer & Oncology Source Type: news

FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
KENILWORTH, N.J.--(BUSINESS WIRE) November 9, 2018 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 9, 2018 Category: Drugs & Pharmacology Source Type: news

Early Development of De Novo HCC After DAA Therapy Early Development of De Novo HCC After DAA Therapy
The results of this study indicate that chronic HCV patients treated either with PegIFN or an all-oral DAA regimen remain at risk for development of de novo hepatocellular carcinoma.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Potential markers identified for early detection and prevention of liver cancer
(Frontiers) A new study offers hope of early detection for hepatocellular carcinoma -- the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. The results show a dramatic increase in expression of sugar-burning 'glycolytic' genes in precancerous cirrhotic livers, associated with a significantly higher risk of developing hepatocellular carcinoma. This could lead to a biomarker which identifies those at risk of malignancy, as well as targets for new treatments. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 31, 2018 Category: Biology Source Type: news

Risk of HCC in NASH Compared to Other Liver Diseases Risk of HCC in NASH Compared to Other Liver Diseases
What is the pooled risk of hepatocellular carcinoma, as compared to other liver diseases, in patients with NASH with and without cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 24, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Updated data showed that Roche's Tecentriq in combination with Avastin shrank tumours in people with unresectable or advanced hepatocellular carcinoma (HCC)
Roche will today present updated data from a Phase Ib study evaluating Tecentriq ® (atezolizumab) in combination with Avastin® (bevacizumab) as a treatment for people with unresectable or advanced hepatocellular carcinoma (HCC), the most common form of liver cancer. (Source: Roche Investor Update)
Source: Roche Investor Update - October 21, 2018 Category: Pharmaceuticals Source Type: news

Sleeping beauty helps identify genes involved in a fatty liver-associated liver cancer
(Osaka University) Hepatocellular carcinoma, a deadly form of liver cancer, is increasingly being linked to non-alcoholic fatty liver disease; however, the underlying genetic mechanism of disease progression had remained unknown. Using a Sleeping Beauty mutagenesis screen, Osaka University researchers found that Sav1 and downstream components of the Hippo signaling pathway are drivers of the development of liver cancer associated with fatty liver disease. These findings pave the way for liver cancer treatments targeting the Hippo pathway. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Low PNI Predicts Poor Liver Cancer Outcomes
(MedPage Today) -- Meta-analysis supports prognostic tool for hepatocellular carcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 17, 2018 Category: Gastroenterology Source Type: news

Long-Term Aspirin Use Linked to Reduction in Liver Cancer Risk
WEDNESDAY, Oct. 10, 2018 -- Regular long-term aspirin use is associated with a dose-dependent reduction in the risk for hepatocellular carcinoma (HCC), according to a study published online Oct. 4 in JAMA Oncology. Tracey G. Simon, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 10, 2018 Category: Pharmaceuticals Source Type: news

Risk Factors of HCC After HBsAg Seroclearance Risk Factors of HCC After HBsAg Seroclearance
Which factors might increase risk of hepatocellular carcinoma among patients with chronic hepatitis B who have achieved seroclearance of hepatitis B surface antigen?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Systemic Treatment of Hepatocellular Carcinoma Systemic Treatment of Hepatocellular Carcinoma
This review discusses the evolution of targeted therapy with tyrosine kinase inhibitors and recent developments in immunotherapy for systemic treatment of hepatocellular carcinoma.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 8, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Aspirin Use Tied to Reduced Risk of Liver, Ovarian Cancers
(MedPage Today) --'Strongest evidence to date'in hepatocellular carcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 5, 2018 Category: Gastroenterology Source Type: news

Regular Aspirin Use Curbs Risk of Liver and Ovarian Cancer Regular Aspirin Use Curbs Risk of Liver and Ovarian Cancer
Two new studies show that regular long-term aspirin use was linked to a lower risk of hepatocellular carcinoma and ovarian cancerMedscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Regular aspirin use can lower risk for ovarian, liver cancers
The regular use of aspirin was associated with a reduced risk of two deadly cancers -- ovarian and hepatocellular carcinoma. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 4, 2018 Category: Consumer Health News Source Type: news

Mass. General-led study supports aspirin's ability to reduce liver cancer risk
(Massachusetts General Hospital) The results of a study led by Massachusetts General Hospital investigators support evidence from previous studies suggesting the regular use of aspirin can reduce the risk of developing primary liver cancer -- also called hepatocellular carcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Liquid Biopsy Shows Promise for Monitoring, Detecting Liver Disease Liquid Biopsy Shows Promise for Monitoring, Detecting Liver Disease
Diseased liver cells can be detected in the peripheral blood, and those from patients with hepatocellular carcinoma (HCC) have a different gene expression profile than those from patients with chronic liver disease (CLD) but no cancer, according to new findings in Gastroenterology.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 26, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Association Between PPIs and Hepatocellular Carcinoma Association Between PPIs and Hepatocellular Carcinoma
Might long-term use of proton pump inhibitors increase the risk of hepatocellular carcinoma?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news